Rhone Ma Holdings Bhd (5278) - Total Liabilities

Latest as of December 2025: RM82.80 Million MYR ≈ $20.79 Million USD

Based on the latest financial reports, Rhone Ma Holdings Bhd (5278) has total liabilities worth RM82.80 Million MYR (≈ $20.79 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 5278 cash flow conversion to assess how effectively this company generates cash.

Rhone Ma Holdings Bhd - Total Liabilities Trend (2015–2025)

This chart illustrates how Rhone Ma Holdings Bhd's total liabilities have evolved over time, based on quarterly financial data. Check Rhone Ma Holdings Bhd (5278) asset resilience to evaluate the company's liquid asset resilience ratio.

Rhone Ma Holdings Bhd Competitors by Total Liabilities

The table below lists competitors of Rhone Ma Holdings Bhd ranked by their total liabilities.

Company Country Total Liabilities
Brunswick Exploration Inc
V:BRW
Canada CA$808.36K
TNR Gold Corp.
V:TNR
Canada CA$33.13K
FNC ADD CULTURE. Co. Ltd
KQ:063440
Korea ₩5.94 Billion
Sangji Caelum Inc
KQ:042940
Korea ₩115.78 Billion
IL&FS Engineering and Construction Company Limited
NSE:IL&FSENGG
India Rs48.45 Billion
Orad-M
TA:ORAD
Israel ILA79.34 Million
TAEYANG Corporation
KQ:053620
Korea ₩27.99 Billion
VirTra Inc
NASDAQ:VTSI
USA $8.85 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Rhone Ma Holdings Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Rhone Ma Holdings Bhd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.04 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.47 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.32 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Rhone Ma Holdings Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Rhone Ma Holdings Bhd (2015–2025)

The table below shows the annual total liabilities of Rhone Ma Holdings Bhd from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 RM82.80 Million
≈ $20.79 Million
+79.08%
2024-12-31 RM46.23 Million
≈ $11.61 Million
-33.58%
2023-12-31 RM69.61 Million
≈ $17.48 Million
+5.31%
2022-12-31 RM66.10 Million
≈ $16.60 Million
+2.57%
2021-12-31 RM64.44 Million
≈ $16.18 Million
+4.14%
2020-12-31 RM61.88 Million
≈ $15.54 Million
+48.93%
2019-12-31 RM41.55 Million
≈ $10.43 Million
+55.20%
2018-12-31 RM26.77 Million
≈ $6.72 Million
-6.18%
2017-12-31 RM28.53 Million
≈ $7.16 Million
+13.94%
2016-12-31 RM25.04 Million
≈ $6.29 Million
-10.73%
2015-12-31 RM28.05 Million
≈ $7.04 Million
--

About Rhone Ma Holdings Bhd

KLSE:5278 Malaysia Drug Manufacturers - Specialty & Generic
Market Cap
$38.74 Million
RM154.30 Million MYR
Market Cap Rank
#22911 Global
#540 in Malaysia
Share Price
RM0.70
Change (1 day)
+0.72%
52-Week Range
RM0.61 - RM0.72
All Time High
RM1.04
About

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory servic… Read more